# Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome

Study · id `cardio:ct-nct05726019` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05726019](<https://clinicaltrials.gov/study/NCT05726019>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05726019

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT05726019. Randomized; single masking; primary purpose prevention. Start 2022-02-05 (actual); primary completion 2025-12-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05726019, source copy `cardio:ctgov-nct05726019-2026-03-03`, retrieved 2026-10-26)
- Started: 2022-02-05 (actual) (ClinicalTrials.gov record NCT05726019, source copy `cardio:ctgov-nct05726019-2026-03-03`, retrieved 2026-10-26)
- Primary completion: 2025-12-21 (actual) (ClinicalTrials.gov record NCT05726019, source copy `cardio:ctgov-nct05726019-2026-03-03`, retrieved 2026-10-26)
- Completion: 2025-12-21 (actual) (ClinicalTrials.gov record NCT05726019, source copy `cardio:ctgov-nct05726019-2026-03-03`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT05726019, source copy `cardio:ctgov-nct05726019-2026-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05726019-2026-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
- Acronym: COCAR
- Condition: Coronary Artery Disease
- Condition: Acute Coronary Syndrome
- Condition: Coronary Artery Bypass
- Condition: Myocardial Reperfusion
- Condition: Postpericardiotomy Syndrome
- Condition: Postoperative Atrial Fibrilation
- Condition: Perioperative Myocardial Infarction
- Intervention (Drug): Colchicine
- Lead sponsor: University of Sao Paulo General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo General Hospital (`cardio:org-university-of-sao-paulo-general-hospital`)

## Provenance

Content hash: 2b2c9d084b0acb3c4ed1cebf1c461d9094fdad6f2662e131c3eeb6be56f33e1a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
